HMGB1 and neoplasm: The extracellular release of the high-mobility group box-1 (HMGB1) protein by the dying tumor cells, which facilitates cross-presentation of shed tumor antigens by dendritic cells to activate tumor-specific cytotoxic T cells, is an integral mechanism of the oxaliplatin-induced ICD [3, 7, 8].